In this company video update President and COO, Matthew Mills discusses the company's continued progress with E-Commerce distribution as well as the momentum that continues building with multiple investment banking opportunities including a new promising investment banker / broker-dealer relationship.
As we get closer to spring the company is excited for things to continue ramping up especially on the Nature-Cide brand. This is the time of year where things start thawing out and action really starts to pick up again on the Pest Control side of the business.
The Nature-Cide footprint continues to grow year after year and as Matthew described in the video you can see the growth by looking at our Certified Partner Map on the Nature-Cide website. See link below.
https://nature-cide.com/pages/store-locator
This map showcases individual companies from all over the country who carry our products and regularly service their clients with Nature-Cide. This map is growing every day and we feel confident this will only continue to expand as more marketing initiatives go into place to reach consumers directly helping provide more business to our commercial pest control customers.
US Capital Global continues to work hard on building its presentation and business plan to begin presenting the company to potential large-scale investors sometime during the first quarter of 2021.
Our progress with the NewChip accelerator is also moving along nicely. We have done an extensive amount of work and our presentation has been approved to begin the introduction process to various large-scale and mid-level investment banking, family offices and venture capital firms. Everyone at NewChip appears to be very excited about highlighting us at the upcoming demo day starting on March 22 through March 26th. We feel the company will present itself strongly with our eco-friendly story as well as our solid traction.
Meetings with investors will come before and after the Demo Day week event, we will be sure to keep everyone updated on this at the end of the month.
On March 2nd we engaged with the Dalmore Group. The Dalmore Group is a financial firm and broker-dealer that has had unparalleled success helping companies successfully raise capital using Regulation A+. As our new broker-dealer, we feel confident their network of resources will not only give us the ability to save money while we raise capital but also bolster our reach and give us tools and other leadership to get us closer to our goals.
Products have been loaded and sales are starting to come in on the Walmart Marketplace and the Kroger Marketplace. This is a great sign where we could see continued growth as optimization is still in the beginning stages and marketing has not started yet, as we make sure the bugs are out of the system during this launch process. We are hopeful that as we continue to get invited and gain access to bigger audiences the brands will continue to grow.
As Matthew discussed we are in a unique position with our company having the support of all our shareholders. Please help our efforts on Kroger by going to the following link and buying a product and once it arrives, please return to the Kroger Marketplace website and write a short review.
https://www.kroger.com/search?query=nature-cide&searchType=default_search&fulfillment=all
These platforms run on algorithms and any positive feedback we can kick start will help the products get in front of more people. Thank you for your support on this.
The team plans to continue to work hard as we enter the spring and summer months which are so important to our company and as the management team continues to dig in and work tirelessly on finding the right investment banking partner.
We are very grateful to have all of our shareholders’ continued support of our project.
If you have any questions you can contact us at any time at info@medx-rx.com, or call us at 818-349-2870 as well as contact your investor relations representative directly.
DISCLAIMER AND FORWARD-LOOKING STATEMENTS
The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the NEW Offering Circular as well as all Securities Exchange Commission filings before making any investment in the Company.
This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.